Repligen | Операционный Доход



Operating Profit Изменить Дата
Agilent USD 376M 32M 2025-01
Align Technology USD 131.1M 13.05M 2025-03
Bio Techne USD 47.42M 7.43M 2024-12
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Bruker USD 64.1M 4M 2024-12
Charles River Laboratories USD -167687000 285.09M 2024-12
Danaher USD 1.28B 142M 2025-03
Dentsply International USD -509000000 47M 2024-12
Exact Sciences USD -96010000 780.34M 2025-03
General Electric USD 1.74B 345M 2025-03
Henry Schein USD 155M 2M 2024-12
Illumina USD 175M 566M 2024-12
IQVIA Holdings USD 492M 134M 2025-03
Mettler Toledo International USD 201.94M 112.6M 2025-03
Myriad Genetics USD -29000000 10M 2025-03
Pfizer USD 3.67B 4.08B 2025-03
Repligen USD 6.58M 43.08M 2025-03
Revvity USD 72.23M 46.52M 2025-03
Standard Biotools USD -32817000 1.1M 2024-12
Thermo Fisher Scientific USD 1.72B 300M 2025-03
Waters USD 151.74M 140.52M 2025-03
West Pharmaceutical Services USD 107M 52.6M 2025-03



Repligen Операционный Доход - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - May 2025.